1442471-26-2

Basic information

• Product Name: ethyl 2-(5-amino-2-bromo-4-fluorophenyl)acetate
• Synonyms: ethyl 2-(5-amino-2-bromo-4-fluorophenyl)acetate
• CAS NO: 1442471-26-2
• Molecular Weight: 276.105
• Mol File: 1442471-26-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: ethyl 2-(5-amino-2-bromo-4-fluorophenyl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 2-(5-amino-2-bromo-4-fluorophenyl)acetate(1442471-26-2)
• EPA Substance Registry System: ethyl 2-(5-amino-2-bromo-4-fluorophenyl)acetate(1442471-26-2)

Safety Data

• Hazardous Substances Data: 1442471-26-2(Hazardous Substances Data)

Usage

General Description

Ethyl 2-(5-amino-2-bromo-4-fluorophenyl)acetate is a chemical compound with the molecular formula C10H11BrFNO2. It is an ester derived from the conjugate addition of an amine and a bromine-substituted phenyl group to an α,β-unsaturated ester. ethyl 2-(5-amino-2-bromo-4-fluorophenyl)acetate is often used in organic synthesis and pharmaceutical research as a building block for the synthesis of more complex molecules. Its unique structural features make it a valuable intermediate in the production of pharmaceuticals, agrochemicals, and other advanced materials. Additionally, its potential applications in drug discovery and chemical biology make it a valuable tool for researchers in various scientific and industrial fields.

Upstream product

• 61150-59-2 2-(2-bromo-4-fluorophenyl)acetic acid 
• 1012879-09-2 2-(2-bromo-4-fluoro-5-nitrophenyl)acetic acid 
• 1012879-10-5 ethyl 2-(2-bromo-4-fluoro-5-nitrophenyl)acetate 
• 858972-17-5 ethyl 2-(3-amino-4-fluorophenyl)acetate 
• 192508-36-4 2-(4-fluoro-3-nitrophenyl)acetic acid 

Downstream Products

• 1012879-19-4 ethyl 2-(5-amino-2-cyano-4-fluorophenyl)acetate 
• 1442474-39-6 3-(3-(2-bromo-4-fluoro-5-(3-phenylureido)phenyl)-1-ethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-7-yl)-1,1-dimethylurea 
• 1442474-38-5 1-(4-bromo-5-(7-chloro-1-ethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea 
• 1442473-84-8 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-(3-((4-methylpiperazin-1-yl)methyl)phenyl)urea 
• 1442473-74-6 1-(4-cyano-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea 
• 1442473-73-5 4-amino-2-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-5-fluorobenzonitrile 
• 1442473-72-4 4-amino-2-(7-chloro-1-ethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-5-fluorobenzonitrile 
• 1442470-53-2 3-(5-amino-2-bromo-4-fluorophenyl)-1-ethyl-7-(methylamino)-1,6-naphthyridin-2(1H)-one 
• 1442473-40-6 N-(3-(2-bromo-4-fluoro-5-(3-phenylureido)phenyl)-1-ethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-7-yl)-2-cyanoacetamide 
• 1442473-19-9 1-(4-bromo-2-fluoro-5-(1-methyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)phenyl)-3-phenylurea 
• 1442473-17-7 3-(5-amino-2-bromo-4-fluoro-phenyl)-1-methyl-7-methylamino-1H-[1,6]naphthyridin-2-one 
• 1442473-11-1 1-(5-(7-acetamido-1-ethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-4-bromo-2-fluorophenyl)-3-phenylurea 
• 1442473-09-7 1-(5-(7-amino-1-ethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-4-bromo-2-fluorophenyl)-3- phenylurea 
• 1442473-07-5 1-(5-(7-(4-methoxybenzylamino)-1-ethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-4-bromo-2-fluorophenyl)-3-phenylurea 

Relevant articles and documents

Method for preparing repitinib

The invention relates to a method for synthesizing and preparing a new drug repitinib. By utilizing the synthesis and preparation method disclosed by the invention, the compound, namely the repitinib shown in the formula I, can be rapidly and effectively prepared in six steps of chemical reactions. According to the synthetic reaction, the reaction steps and the post-treatment steps are greatly simplified, the reaction conditions are mild, industrial industrialization is easy to realize, and the production cost is lower and more economical.

Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases

The invention relates to dihydronaphthyridines and related compounds; compositions comprising an effective amount of a dihydronaphthyridine or a related compound; and methods for treating or preventing proliferative diseases comprising the administration of an effective amount of a dihydronaphthyridine or a related compound.